The Use of Opioids in Pain Management
Release Date: Oct 15, 2008    Expiration Date: Oct 14, 2009
Credits Available
1 Credit is available for Physicians
Faculty

Perry G. Fine, MD
Professor
Department of Anesthesiology
Pain Research and Management Centers
University of Utah, School of Medicine
Salt Lake City, Utah

Faculty Disclosure
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose to the participant any relevant affiliation or other financial relationship (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation, and (2) with any commercial supporters of the activity. Conflict resolution must occur prior to the CME/CE activity. The ACHL also requires participating faculty to disclose when unapproved/unlabeled uses of a product are discussed in a CME/CE activity.

Faculty members have provided the following disclosure information.

Perry G. Fine, MD, has received honoraria as an advisory board member/consultant for Abbott, Alpharma, Cephalon, Endo, Lilly, Janssen-Ortho-McNeil (PriCara), and Wyeth.

Dr. Fine discloses that this activity discusses the unapproved/off-label use of analgesic medications for the treatment of acute and chronic pain conditions
Disclaimer
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Essential Areas and Elements, Policies, and Standards for Commercial Support as well as the ACPE Criteria for Quality and Interpretive Guidelines. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis.

Participants are advised that one or more presentations in this CME/CE activity may contain references to unapproved or unlabeled uses of drugs or devices. Participants should note that the use of these agents outside current approved labeling is considered investigational and are advised to consult current prescribing information for these products.
Disclosure
The ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Copyright © 2010 ACHL